Medicine News and Research

RSS

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.

30 Nov 2010

Prescription rates for controlled medications double for teens, young adults

Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.

30 Nov 2010

AIDS Healthcare Foundation to participate in Members Project

AIDS Healthcare Foundation (AHF) is proud to be selected as a candidate charity in Members Project, a partnership between American Express and TakePart.

30 Nov 2010

New tool helps doctors gauge how well they care for people with Parkinson's disease

The American Academy of Neurology has developed a new tool to help doctors gauge how well they are caring for people with Parkinson's disease. The new quality measures are published in the November 30, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology.

30 Nov 2010

Canon introduces high-resolution installation projector for medical education

Canon U.S.A., Inc., a leader in digital imaging, today introduced the REALiS WUX4000 D Installation LCOS Projector, the Company's first high-resolution installation projector for the medical education market.

30 Nov 2010

Majority of Americans and Canadians are getting enough vitamin D and calcium, says report

The majority of Americans and Canadians are getting enough vitamin D and calcium to meet their needs, says a new report from the Institute of Medicine. Most people up to age 70 need no more than 600 international units, or IUs, of vitamin D per day, and those 71 and older may need as much as 800 IUs, the report finds. The amount of calcium needed ranges, based on age, from 700 to 1,300 milligrams per day.

30 Nov 2010

State legislatures ask: Are insurers practicing medicine without a license?

A survey by the Global Healthy Living Foundation, www.ghlf.org, a non-profit patient advocacy group, shows that up to 70 percent of prescription medications are changed by health insurers, denying patients the drugs their doctors prescribe.

30 Nov 2010

Primary care physicians rank GSK's sales force number one

According to SDI's 2010 Ranking Tables Study, office-based primary care physicians - general practitioners, family medicine physicians, and doctors of osteopathy - rank GlaxoSmithKline's sales force number one, a jump from third in 2009. Pfizer finished second and Merck placed third this year, down from first and second, respectively, in 2009.

30 Nov 2010

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

Neuroscientists at the Centre for Addiction and Mental Health (CAMH) have developed a protein peptide that may be a novel type of highly targeted treatment for depression with a low side-effect profile. Depression affects one in ten Canadians at some time in their lives and is a leading cause of disability worldwide.

30 Nov 2010

GeoVax supports Bionor's Phase 2b trial of therapeutic HIV/AIDS vaccine

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it was pleased to learn of the partial success observed in the recently completed Phase 2b trial of a therapeutic HIV/AIDS vaccine produced by Bionor Immuno AS of Oslo, Norway.

30 Nov 2010

Sinai Hospital's endocrinologist helps people to manage diabetes

Nearly 27-million people live with diabetes and 57-million more are pre-diabetic. Not only can this disease be life threatening, but it can take a huge toll on families and on those who have it- if it's not treated properly.

30 Nov 2010

Nine out of ten of all primary care centers in Sweden prescribe physical activity

Prescribing physical activity for the purpose of preventing and treating various conditions can now become a reality for healthcare professionals all over the world.

30 Nov 2010

New study may lead to non-medicinal methods of eradicating Hamburger disease

Hamburger disease, a debilitating form of food poisoning, may be a thing of the past. New findings from an international research collaboration conducted by the French National Institute for Agronomic Research (INRA), involving the Universit- de Montr-al are the first to show how the contaminating E.coli bacterium is able to survive in the competitive environment of a cow's intestine by scavenging specific food sources.

30 Nov 2010

DTRA presents Outstanding Scientific Achievement award to Aduro BioTech

Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the "Outstanding Scientific Achievement" award from the Defense Threat Reduction Agency. The award was presented at the 2010 Chemical and Biological Defense Science and Technology Conference in Orlando, Florida to Dr. Justin Skoble, Associate Director, Biodefense and Process Development at Aduro BioTech.

30 Nov 2010

IOM report updates DRIs levels of Vitamin D, calcium

Vitamin D and calcium have been the focus of much research since the Institute of Medicine set nutritional reference values for them in 1997. Known as Dietary Reference Intakes, the values for these and other nutrients serve as a guide for good nutrition and provide the scientific basis for the development of food guidelines in both the United States and Canada. Updated DRIs for these two nutrients are presented in a new IOM report, Dietary Reference Intakes for Calcium and Vitamin D, which will be released on Tuesday, Nov. 30.

30 Nov 2010

RCSI researchers discover potential new target for diarrhoea associated intestinal diseases

A study by researchers in the Royal College of Surgeons in Ireland (RCSI) has uncovered a potential new target for the treatment of a range of intestinal diseases that are associated with diarrhoea. Current medications are often ineffective and can have serious side effects so this discovery gives hope for the development of new treatments for sufferers of intestinal disease.

30 Nov 2010

Quintiles, London Genetics enter strategic alliance to offer pharmacogenetics solutions for personalized medicine

Quintiles, the world's leading biopharmaceutical services company, and London Genetics, an expert in the use of pharmacogenetics in drug discovery and development, today announced a strategic alliance to offer the biopharmaceutical industry innovative pharmacogenetics solutions to advance personalized medicine. Financial terms were not disclosed.

30 Nov 2010

Scientists discover a new method to produce gold nanoparticles

Gold nanoparticles, tiny pieces of gold so small that they can't be seen by the naked eye, are used in electronics, healthcare products and as pharmaceuticals to fight cancer. Despite their positive uses, the process to make the nanoparticles requires dangerous and extremely toxic chemicals. While the nanotechnology industry is expected to produce large quantities of nanoparticles in the near future, researchers have been worried about the environmental impact of the global nanotechnological revolution.

30 Nov 2010

Long-term phase 3 trial confirms safety of lubiprostone in Japanese patients with chronic idiopathic constipation

Sucampo Pharmaceuticals, Inc. and Abbott today announced positive top-line data from a 48-week phase 3 long-term safety and efficacy clinical trial of lubiprostone in Japanese patients with chronic idiopathic constipation (CIC). The trial demonstrated that lubiprostone was safe and well-tolerated.

30 Nov 2010

Functional MRI reveals effectiveness of acupuncture in relieving pain

Using functional magnetic resonance imaging (fMRI), researchers have captured pictures of the brain while patients experienced a pain stimulus with and without acupuncture to determine acupuncture's effect on how the brain processes pain. Results of the study, which the researchers say suggest the effectiveness of acupuncture, were presented today at the annual meeting of the Radiological Society of North America (RSNA).

30 Nov 2010

Medicine News and Research

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

Prescription rates for controlled medications double for teens, young adults

AIDS Healthcare Foundation to participate in Members Project

New tool helps doctors gauge how well they care for people with Parkinson's disease

Canon introduces high-resolution installation projector for medical education

Majority of Americans and Canadians are getting enough vitamin D and calcium, says report

State legislatures ask: Are insurers practicing medicine without a license?

Primary care physicians rank GSK's sales force number one

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

GeoVax supports Bionor's Phase 2b trial of therapeutic HIV/AIDS vaccine

Sinai Hospital's endocrinologist helps people to manage diabetes

Nine out of ten of all primary care centers in Sweden prescribe physical activity

New study may lead to non-medicinal methods of eradicating Hamburger disease

DTRA presents Outstanding Scientific Achievement award to Aduro BioTech

IOM report updates DRIs levels of Vitamin D, calcium

RCSI researchers discover potential new target for diarrhoea associated intestinal diseases

Quintiles, London Genetics enter strategic alliance to offer pharmacogenetics solutions for personalized medicine

Scientists discover a new method to produce gold nanoparticles

Long-term phase 3 trial confirms safety of lubiprostone in Japanese patients with chronic idiopathic constipation

Functional MRI reveals effectiveness of acupuncture in relieving pain

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News